RxDoctor Payments Data

Neil Washington

Podiatrist · Lewiston, IDNPI 1679700108

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $951 of the $1,549 with a category attached, or 61.4%. 6 manufacturers reported payments, led by Stryker at 51.2% of the total. Reporting peaked in 2023 at $664 and has fallen 96.4% since, to $24 in 2025.

$1,549in general payments, 2019–2025

Across 19 payments — averaging $81.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$794
  • Anika Therapeutics, Inc.$598
  • Summit Surgical Corp.$52
  • Smith+Nephew$47
  • Sanara Medtech Inc.$35
  • Fusion Orthopedics USA, LLC$24

What the payments were for

  • Travel & lodging$59839%
  • Food & beverage$95161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,549 in reported general payments places this provider in the 65th percentile of 28 podiatrist providers in Idaho.

See all podiatrist providers in Idaho

Medicare billing

Part B allowed, 2024
$128,375
Medicare patients
587
Services billed
1,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Minocycline Hcl56$862
Gabapentin34$670
Ketoconazole20$458
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$200
Oxycodone Hcl11$105

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lewiston

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →